Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03658265
Other study ID # CRE2018013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 10, 2018
Est. completion date May 31, 2020

Study information

Verified date October 2020
Source Wuhan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients who underwent modified radical mastectomy were enrolled in the study. 200 subjects were randomly divided into 4 groups: 7 days postoperative shoulder isotonic training + 4 weeks postoperative progressive resistance training group, postoperative 7 Isometric training for the shoulder joint + progressive resistance training for 3 weeks after surgery group, 3 days postoperative isotope training + 4 weeks postoperative progressive resistance training group, 3 days postoperative shoulder isotonic training + postoperative 3 Weekly progressive resistance training group. The effects of interventional rehabilitation at different time points on the recovery of shoulder function after breast cancer operation were observed. The results of the study will provide evidence-based evidence for the time point of intervention in early functional exercise after modified radical mastectomy for breast cancer.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date May 31, 2020
Est. primary completion date May 31, 2020
Accepts healthy volunteers No
Gender Female
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria:

1. Between the ages of 25 and 75 years;

2. Diagnosed with breast cancer by pathological diagnosis, the time of diagnosis and the time of inclusion are less than 6 weeks;

3. Patients undergoing modified radical mastectomy: mastectomy includes unilateral total breast or breast-conserving surgery, as well as dissection of the affected axillary lymph nodes, but does not include sentinel lymph node biopsy;

4. Postoperative chemotherapy or radiation therapy according to the condition;

5. No other malignant tumors within 5 years;

6. No physical therapy related contraindications;

7. Signing informed consent.

Exclusion Criteria:

1. The result of SLNB is negative who did not receive ALND;

2. Received breast reconstruction surgery (prosthesis, latissimus dorsi, etc.);

3. Combined tumor metastasis with other tissues and organs (liver, kidney, lung, brain, etc.);

4. Combined severe heart disease, cerebrovascular disease, and mental illness;

5. Patients with shoulder joint dysfunction before surgery;

6. Unable to understand the rehabilitation training program provided by doctors or physiotherapists.

Study Design


Intervention

Other:
7 days SIE plus 4 weeks PRE
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity.
7 days SIE plus 3 weeks PRE
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity.
3 days SIE plus 4 weeks PRE
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity.
3 days SIE plus 3 weeks PRE
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity.

Locations

Country Name City State
China Zhongnan hospital of Wuhan University Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Wuhan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Visual Analogue Scale (VAS) Visual Analogue Scale(VAS): Used to assess the degree of pain. Draw a 10 cm horizontal line on the paper. One end of the horizontal line is 0, indicating no pain; the other end is 10, indicating severe pain; the middle part indicates different degrees of pain. 1 day, 3 days, 1 week, 2 weeks after surgery
Other Sum drainage from chest wall and axillary after operation. The postoperative drainage was the total volume of the chest wall drainage tube and the underarm drainage tube. The volume measurement and recording in the drainage bag were observed daily by the nurse. 1 day, 3 days, 1 week, 2 weeks after surgery
Other Upper limb circumference Preoperative 3, 9, 12,18 weeks after surgery
Other body weight Preoperative, 3, 9 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 1 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 3 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 6 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 9 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 12 weeks after surgery
Primary Constant-Murley Shoulder Score The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100. Higher scores indicate better shoulder function. 18 weeks after surgery
Secondary Active and passive range of motion In the standard position, the mobility of the shoulder flexion, extension, external rotation and internal rotation was measured by using protractor. The range of flexion is 0-180°, the range of extension is 0-180°, the range of external rotation is 0-90°, and the range of internal rotation is measured. 0-70°. The assessments will be performed in the active and passive state separately. 3 days,1, 2, 3, 6, and 9 weeks after surgery
Secondary Shoulder joint muscle strength In the standard position, the muscle strength of the flexion, extension, external rotation and internal rotation of the shoulder joint were assessed according to the "manual muscle test standard". 3 days, 3, 6, 9 weeks after surgery
Secondary The power of gripping In the standard position, the grip of the patient's palm is measured using a dynamometer. 1, 3 days and 1, 2, 3, 6, and 9 weeks after surgery
Secondary EORTC QLQ BR23 Breast Cancer Quality of Life Questionnaire The quality of life assessment of breast cancer patients was evaluated by the total score of the EORTC QLQ BR23 Breast Cancer Quality of Life Questionnaire, which ranged from 0 to 92. Higher scores indicate better quality of life. 1, 3, 9, 12, 18 weeks after surgery
Secondary SF-36 Health status questionnaire The quality of life assessment of breast cancer patients was evaluated by the total score of the SF-36 Health status questionnaire, which ranged from 0 to 92. Higher scores indicate better quality of life. 1, 3, 9, 12, 18 weeks after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A